GAIA vs META
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GAIA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the stock trades at a discount to book value (P/B 0.78) and has a low Price/Sales ratio (0.70), these are overshadowed by a critical liquidity crisis evidenced by a Current Ratio of 0.59. Despite a 'Strong Buy' analyst consensus and a high target price of $7.38, the technical trend is 0/100 and the 6-month price performance is -55.8%, suggesting a significant disconnect between analyst projections and market reality.
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
GAIA vs META: Head-to-Head Comparison
This page compares Gaia, Inc. (GAIA) and Meta Platforms, Inc. (META) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.